The preclinical pharmacologic study of dopamine transporter imaging agent [99mTc]TRODAT-1

Nuclear Medicine and Biology

Volumn 27, Issue 1, 2000, Pages 69-75

  Fang, Ping ^a   Wu, Chun Ying ^a   Liu, Zhen Guo ^b   Wan, Wei Xing ^a   Wang, Tie Sheng ^a   Chen, Sheng Di ^b   Chen, Zheng Ping ^a   Zhou, Xiang ^a  

^a JIANGSU INSTITUTE OF NUCLEAR MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

99mTc TRODAT 1; Biodistribution; Dopamine transporter; Parkinson's disease; Pharmacokinetics; Radionuclide imaging

Indexed keywords

DOPAMINE TRANSPORTER; TECHNETIUM 99M; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN SCINTISCANNING; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STABILITY; DRUG UPTAKE; MONKEY; NONHUMAN; PARKINSON DISEASE; RABBIT; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG STABILITY; HAPLORHINI; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METABOLIC CLEARANCE RATE; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0033968960     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00090-6     Document Type: Article

References (24)

1. Abi-Dargham A., Gandelsman M.S., DeErausquin G.A., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Laruelle M., Charney D.S., Hoffer P.B., Neumeyer J.L., Innis R.B. SPECT imaging of dopamine transporter in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J. Nucl. Med. 37:1996;1129-1133.
2. Asenbaum S., Brucke T., Pirker W., Podreka I., Angelberger P., Wagner S., Wober C., Muller C., Deecke L. Imaging of dopamine transporters with iodine-123 β-CIT and SPECT in Parkinson's disease. J. Nucl. Med. 38:1997;1-6.
3. Carroll F.I., Kotian P., Dehghani A., Gray J.L., Kuzemko M.A., Parham K.A., Abraham P., Lewin A.H., Boja J.W., Kuhar M.J. Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 38:1995;379-388.
4. 99mTc]TRODAT-1 to the central dopamine transporters in rats. Eur. J. Nucl. Med. 25:1998;31-39.
5. 99mTc]TRODAT-1 as a dopamine transporters imaging agent (abstract). J. Labelled Cmpd. Radiopharm. 42:(suppl. 1):1999;S336-S338.
6. 99mTc]TRODAT-1 as a dopamine transporters imaging agent. ZHONGHUA HEYIXUE ZAZHI. 19:1999;146-148. (in Chinese).
7. Goodman M.M., Keil R., Shoup T.M., Eshima D., Eshima L., Kilts C., Votaw J., Camp V.M., Votaw D., Smith E., Kung M.P., Malveaux E., Watts R., Huerkamp M., Wu D., Garcia E., Hoffman J.M. Fluorine-18-FPCIT A PET radiotracer for imaging dopamine transporter . J. Nucl. Med. 38:1997;119-126.
8. Goodman M.M., Kung M.P., Kabalka G.W., Kung H.F., Switzer R. Synthesis and characterization of radioiodinated N- (3-iodopropen-1-yl)-2β-carbomethoxy-3β-(4-chlorophenyl) tropanes Potential dopamine reuptake site imaging agents . J. Med. Chem. 37:1994;1535-1542.
9. Kaufman M.J., Madras B.K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's disease striatum. Synapse. 9:1991;43-49.
10. Kung H.F., Kim H.J., Kung M.P., Meegalla S.K., Plossl K., Lee H.K. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur. J. Nucl. Med. 23:1996;1527-1530.
11. 99mTc]TRODAT-1 A novel technetium-99m complex as a dopamine transporter imaging agent . Eur. J. Nucl. Med. 24:1997;372-380.
12. Kung M.P., Essman W.D., Frederick D., Meegalla S.K., Goodman M., Mu M., Lucki I., Kung H.F. IPT A novel iodinated ligand for the CNS dopamine transporter . Synapse. 20:1995;316-324.
13. 99mTc] probe to label the dopamine transporter in brain by SPECT imaging . Synapse. 22:1996;239-246.
14. Meegalla S., Plossl K., Kung M.P., Chumpradit S., Stevenson D.A., Kushner S.A., McElgin W.T., Mozley P.D., Kung H.F. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents. J. Med. Chem. 40:1997;9-17.
15. 99mTc-labeled tropanes as dopamine transporter imaging agents. Bioconjug. Chem. 7:1996;421-429.
16. 99mTc] complex as a dopamine transporter imaging agent. J. Am. Chem. Soc. 117:1995;11037-11038.
17. Meltzer P.C., Liang A.Y., Brownell A.L., Elmaleh D.R., Madras B.K. Substituted 3-phenyltropane analogs of cocaine Synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging . J. Med. Chem. 36:1993;855-862.
18. Mozley P.D., Stubbs J.B., Plossl K., Dresel S.H., Barraclough E.D., Alavi A., Araujo L.I., Kung H.F. Biodistribution and dosimetry of TRODAT-1 A technetium-99m tropane for imaging dopamine transporters . J. Nucl. Med. 39:1998;2069-2076.
19. Seibyl J.P., Marek K., Sheff K., Zoghbi S., Baldwin R.M., Charney D.S., Dyck C.H., Innis R.B. Iodine-123-β-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J. Nucl. Med. 39:1998;1500-1508.
20. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., Kuhar M., Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-577.
21. Tamagan G., Gao Y., Baldwin R.M., Zoghbi S.S., Neumeyer J.L. Synthesis of β-CIT-BAT, a potential technetium-99m imaging ligand for dopamine transporter. Tetrahedron Lett. 37:1996;4353-4356.
22. The Pharmacopoeia Commission of PRC. (1992) The Pharmacopoeia of the People's Republic of China (English edition). The People's Medical Publishing House: Beijing. Appendix 16, p A101.
23. 11C]WIN35,428 positron emission tomography (PET) (abstract). J. Nucl. Med. 34:1993;S197.
24. 99mTc (abstract). J. Nucl. Med. 38:1997;S100.